Market Performance
Regencell Bioscience (RGC) closed at USD 10.05 on popular exchanges during the 24‑hour period ending at 06:50 AM Central Europe on Wednesday, 21 March 2026. The stock traded up 4.8 % on that day, contributing to an overall 69.76 % increase since the previous month‑end.
| Item | Value |
|---|---|
| Current price | USD 10.05 |
| 24‑hour volume | USD 8.4 million |
| Shares outstanding | 496.4 million |
| Market capitalisation | USD 4.8 billion |
| Simple moving average (200 days) | USD 18.44 |
| 52‑week high | USD 69.00 (01 August 2026) |
| 52‑week low | USD 4.51 (17 July 2026) |
Recent Trading Activity
Over the last 24 hours, Regencell’s trading volume was USD 8.4 million, indicating moderate liquidity relative to its market cap. The upward price movement aligns with a positive trend observed over the past month.
Technical Indicators
- The 200‑day simple moving average (SMA) is currently at USD 18.44, well above the current trading price, suggesting a potential short‑term support level.
- The 52‑week high of USD 69.00 and low of USD 4.51 provide a context for evaluating short‑term volatility.
Peer Comparison (24‑Hour Performance)
| Stock | Symbol | 24‑Hour Change | Current Price | Market Capitalisation | Additional Note |
|---|---|---|---|---|---|
| Tcl Electronics | 1070.HK | –1.09 % | HKD 17.22 | HKD 43.7 bn | P/E = 14.14 |
| Momenta Global | 6880.HK | +4.88 % | HKD 171.00 | HKD 40.5 bn | — |
| Tsim Sha Tsui Properties | 0247.HK | 0 % | HKD 19.35 | HKD 43.6 bn | P/E = 15.74 |
| Pccw | 0008.HK | +0.68 % | HKD 5.14 | HKD 40.3 bn | — |
| Fwd | 1828.HK | +1.10 % | HKD 31.54 | HKD 39.9 bn | — |
Regencell’s performance is comparatively stronger than some peers (e.g., Tcl Electronics) and comparable to others (e.g., Pccw, Fwd). The company’s upward trajectory over the past month outpaces the more modest gains of several peers.
Company Overview
Regencell Bioscience Holdings Limited is a holding company focused on the research, development, and commercialization of traditional medicine products for neurocognitive disorders and degeneration. The company operates through subsidiaries that supply products globally. Regencell is listed on the Nasdaq stock exchange. Further details are available on the company’s website: www.regencellbioscience.com .
All figures are current as of the specified trading time and are presented for informational purposes only.
